Mycetoma: Management for the First Contact Doctor

Article Sidebar

PDF
Published: Mar 16, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i3-31
Keywords:
.

Main Article Content

Susana González Hernández
Hospital General Dr. Dario Fernandez Fierro. Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Ciudad de México, México.
Jacqueline Edith Mut Quej
Hospital General de Zona con Medicina Familiar 1. Instituto Mexicano del Seguro Social. Campeche, Campeche, México.
Jaime Picazo Luna
Hospital General de Zona 194 Instituto Mexicano del Seguro Social. Naucalpan de Juárez, México.
Nayeli Guadalupe Gonzalez Bonilla
Hospital General de Zona con Medicina familiar 1.Instituto Mexicano del Seguro Social. La Paz, Baja California Sur, México.
María Cristina Ponce Figueroa
Hospital general de zona 67. Instituto Mexicano del Seguro Social. Apodaca, Nuevo León, México.

Abstract

Mycetoma is a chronic infection of the skin and underlying tissues caused by fungi or bacteria. It is endemic to tropical regions, mainly affecting men, peasants, between the third and fourth decade of life. The clinical picture is characterized by increased volume, deformity of the anatomical area, and fistulas that drain a stringy exudate with the presence of "pimples." The diagnosis and determination of the etiological agent is carried out by direct analysis and culture of the secretion.

Article Details

How to Cite
Susana González Hernández, Jacqueline Edith Mut Quej, Jaime Picazo Luna, Nayeli Guadalupe Gonzalez Bonilla, & María Cristina Ponce Figueroa. (2023). Mycetoma: Management for the First Contact Doctor. International Journal of Medical Science and Clinical Research Studies, 3(3), 466–468. https://doi.org/10.47191/ijmscrs/v3-i3-31
Issue
Vol. 3 No. 3 (2023): Volume 03 Issue 03 March 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Mcginnis MR. Mycetoma. Dermatol Clin 1996; 14: 97-104.

II. Salamon M, Lee E, Pinney S. Madura Foot (Madurella Mycetoma) presenting as a plantar fibroma: A case report. Foot Ankle Int 2006; 27: 212-5.

III. Lavalle P. Micetomas por streptomices en América. Dermatología Ibero Americana 1972; 3: 379-89.

IV. Lavalle P, Padilla M, Pérez J, Rivera I, Reynoso S. Micetomas por Actinomadurae en México. RevCent Dermatol Pascua 2000; 9: 19-24.

V. Ispoglou SS, Zormpala A, Androulaki A, Sipsas NV. Madura foot due to Actinomadurae imaging appearance. Clin Imaging 2003; 27: 233-5.

VI. Dieng MT, Sy MH, Diop BM, Niang SO, Ndiaye B. Mycetoma: 130 cases. Ann Dermatol Venereol 2003; 130 (1Pt1): 16-9.

VII. Pérez-Blanco M, Hernández-Valles R, Fernández- Zeppenfeldt G, Yegres F. Mycetoma: report of 3 cases in Falcon State, Venezuela. Invest Clin 1996; 37: 61-73.

VIII. Buot G, Lavallep, Mariat F, Súchil P. Epidemiologic study of mycetomas in México. Apropos of 502 cases. Bull Soc Pathol Exot Filiales 1987; 80: 329-39.

IX. Tight RR, Bartlett MS. Actinomycetoma in the United States. Rev Infect Dis 1981; 3: 1139-50.

X. Vera-Cabrera L, Ochoa-Felix E, González G, Tijerina R, Choi S, Welsh O. In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae. Antimicrob Agents Chemother 2004; 48: 1037-9.

XI. Verma P, Jha A. Mycetoma: reviewing a neglected disease. Clin Exp Dermatol. 2019;44(2):123-9.

XII. Van de Sande WW. Global burden of human mycetoma: a systematic review and metaanalysis. PLoS Negl Trop Dis. 2013;7(11):e2550.

XIII. Villa-Escobar AM, Cardona-Castro N. Micetoma. CES Medicina. 2008;22(1):8.

XIV. Zijlstra EE, Van De Sande WW, Welsh O, Goodfellow M, Fahal AH. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 2016;16(1):100-12.

Most read articles by the same author(s)